Where is Cryopal located?

Cryopal is headquartered in Bussy Saint Georges, France.

How many employees does Cryopal have?

As of Aug 31, 2026, the latest employee count at Cryopal is 88.

Where does Cryopal rank among its competitors?

Cryopal ranks 7th amongst 26 active competitors, of which 5 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Genepoint Biological Technology, which secured $29.5M in Jan, 2023.

Who are the top competitors of Cryopal?

Cryopal's top competitors include Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology. Among them, Genepoint Biological Technology secured the most recent funding round in January, 2023.

Cryopal - 2026 Company Profile, Funding & Competitors

Cryopal is a funded company based in Bussy Saint Georges (France), founded in 1968. It operates as a Provider of cryo-preservation equipment and services. The company has 26 active competitors, including 5 funded and 5 that have exited. Its top competitors include companies like Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology.

Company Details

Cryopal is a provider of cryo-preservation equipment and services. The company provides solutions for cryopreservation, animal insemination, oxygen therapy, dermatology, and helium applications. It offers products like cryogenic vessels, vacuum lines, surveillance systems, and Accessories. It also offers turnkey solutions for the design, development and installation of cryopreservation equipment.

Website: cryopal.com/fr/accueil
Social
Email ID: *****@airliquide.com
Phone Number: +33 **********

Key Metrics

Founded Year

1968

Location

Bussy Saint Georges, France

Stage

Funding Raised

Investors

Initiative & Finance

Ranked

7^th among 26 active competitors

Employee Count

88 as on Aug 31, 2026

Similar Companies

Stirling Ultracold & 24 more

View Cryopal's full profile

Cryopal is a funded company. Cryopal has 1 institutional investor.

View details of Cryopal's funding rounds and investors

Cryopal's employee count trend

Cryopal has 88 employees as of Aug 26. Here is Cryopal's employee count trend over the years:

Uncover Cryopal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cryopal include Stirling Ultracold, PanTHERA CryoSolutions and Genepoint Biological Technology. Here is the list of Top 10 competitors of Cryopal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Stirling Ultracold 2009, Athens (United States), Acquired	Manufacturer of freezer for storage and preservation	$8.7M	Ohio Innovation Fund, Square 1 Bank & 5 others	50/100
2nd	PanTHERA CryoSolutions 2018, Edmonton (Canada), Acquired	Provider of a platform for cell cryopreservation	$6M	Casdin Capital, BioLife Solutions & 1 others	40/100
3rd	Genepoint Biological Technology 2015, Shanghai (China), Series D	Platform for cryostorage and long-term preservation	$48.3M	NLVC, New Hope Group & 8 others	39/100
4th	Vitrafy 2018, Ballarat (Australia), Public	Developer of cryopreservation system for human blood products and advanced cellular therapies	-	-	38/100
5th	Montana Instruments 2008, Bozeman (United States), Acquired	Cryogenic solutions provider accelerating quantum discovery with reliable, low-temperature environments	-	-	38/100
6th	Cell Matters 2017, Liege (Belgium), Series A	CDMO focused on manufacturing of cell therapy products	$872K	Paip investissements, Noshaq & 2 others	35/100
7th	Cryopal 1968, Bussy Saint Georges (France), Funding Raised	Provider of cryo-preservation equipment and services	-	Initiative & Finance	31/100
8th	OriGen Biomedical 1996, Austin (United States), Unfunded	Innovating cryopreservation and cell culture solutions for regenerative medicine	-	-	29/100
9th	Evia Bio 2021, Minneapolis (United States), Funding Raised	Provider of cryopreservation technology for the cell therapy supply chain	-	Pleasant Bay Capital Partners	24/100
10th	MFC Global 2013, Rishon Lezion (Israel), Unfunded	Developer of a device for cryopreservation of spermatozoa	-	-	26/100